Cargando…
Mitochondrial determinants of chemoresistance
Chemoresistance constitute nowadays the major contributor to therapy failure in most cancers. There are main factors that mitigate cell response to therapy, such as target organ, inherent sensitivity to the administered compound, its metabolism, drug efflux and influx or alterations on specific cell...
Autores principales: | Bokil, Ansooya, Sancho, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992520/ https://www.ncbi.nlm.nih.gov/pubmed/35582564 http://dx.doi.org/10.20517/cdr.2019.46 |
Ejemplares similares
-
Lipid droplets as metabolic determinants for stemness and chemoresistance in cancer
por: Royo-García, Alba, et al.
Publicado: (2021) -
Glioblastoma chemoresistance: roles of the mitochondrial melatonergic pathway
por: Anderson, George
Publicado: (2020) -
Author Correction: Metformin treatment response is dependent on glucose growth conditions and metabolic phenotype in colorectal cancer cells
por: Alhourani, Abdelnour H., et al.
Publicado: (2022) -
Metformin treatment response is dependent on glucose growth conditions and metabolic phenotype in colorectal cancer cells
por: Alhourani, Abdelnour H., et al.
Publicado: (2021) -
Opposite and dynamic regulation of the interferon response in metastatic and non-metastatic breast cancer
por: Lamsal, Apsana, et al.
Publicado: (2023)